Iqvia Holdings Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Iqvia Holdings Inc 's ROA in the first quarter of 2026?
Iqvia Holdings Inc achieved a return on average assets (ROA) of 4.72 % in its first quarter of 2026, which is below Iqvia Holdings Inc 's average return on assets, which stands at 5.07%.

ROA decreased relative to the period ending Dec 31 2025, due to the decline in net income.

However, within the Healthcare sector 156 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 1227, from total ROA ranking in the fourth quarter of 2025 at 1426.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	9.92 %	12.52 %	5.69 %	8.46 %	2.81 %
Y / Y Net Income Change	10.44 %	17.62 %	16.49 %	-26.72 %	-13.54 %
Net Income (TTM) in million	1,387	1,361	1,284	1,237	1,334
Return On Assets (TTM)	4.72 %	4.74 %	4.6 %	4.5 %	4.95 %
IQV's Total Ranking	# 1227	# 1426	# 1254	# 1273	# 1211
Total Assets (TTM) in million	30,032	30,268	28,727	28,632	27,322
Seq. Total Assets Change	-0.78 %	5.36 %	0.33 %	4.79 %	1.57 %
Seq. Net Income Change	-46.5 %	54.82 %	24.81 %	6.83 %	-43.02 %

IQV's 5 Years Annual ROA >> Back to IQV Management Effectiveness >> Compare IQV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 10
Sector	# 157
Overall	# 1220

Return On Assets Statistics
High	Average	Low
11.45 %	5.07 %	0.35 %
(Dec 31 2014)		(Sep 30 2017)

Financial Statements
Iqvia Holdings Inc 's Assets	$ 30,032 million	IQV's Balance sheet
Iqvia Holdings Inc 's Income	$ 275 million	Quarterly IQV's Income Statement
IQV's Income by Division		See IQV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	12.52 %	0.82 %	5.3 %	2.62 %	0.51 %
Total Assets in million	30,268	26,899	26,681	25,337	24,689
Y / Y Net Income Change	-0.87 %	1.1 %	24.47 %	12.36 %	215.26 %
Net Income in million	1,361	1,373	1,358	1,091	971
Annual Return On Assets	4.5 %	5.1 %	5.09 %	4.31 %	3.93 %

IQV's 5 Years Annual ROA >> Back to IQV Management Effectiveness >> Compare IQV ROA to its Competitors

Comment on IQV's ROA in the fiscal year ending 2025

In the fiscal year 2025 Iqvia Holdings Inc 's ROA decreased compared to previous year to 4.5 %, due to deterioration of net income -0.87 % to $1,361.00 million, from $1,373.00 million a year ago, as IQV's assets were $30,268.00 million.

More Return On Assets Ratios
IQV's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IQV's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IQV's Competitors
Subscribers only: Roa for Iqvia Holdings Inc 's Suppliers
Subscribers only: Return On Assets for IQV's Customers

You may also want to know
IQV's Roi	IQV's Inventory Turnover Ratio	IQV's Growth Rates	IQV's Dividend Comparisons
	IQV's Profitability Ratios	IQV's Asset Turnover Ratio	IQV's Dividend Growth
IQV's Roe	IQV's Valuation Ratios	IQV's Financial Strength Ratios	IQV's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector	ROA
Hca Healthcare Inc	12.94 %
Lantheus Holdings Inc	12.45 %
Puma Biotechnology Inc	12.09 %
Harmony Biosciences Holdings inc	11.99 %
Carlisle Companies Incorporated	11.97 %
Alnylam Pharmaceuticals Inc	11.71 %
Sbc Medical Group Holdings Incorporated	11.64 %
Medinotec Inc	11.60 %
Encompass Health Corporation	11.56 %
Alpha Pro Tech Ltd	11.43 %
Msa Safety Inc	11.37 %
Globus Medical Inc	11.28 %
Agilent Technologies inc	11.15 %
Ligand Pharmaceuticals Incorporated	11.13 %
Regeneron Pharmaceuticals Inc	11.07 %
Johnson and Johnson	10.70 %
Ufp Technologies Inc	10.49 %
Lemaitre Vascular Inc	10.31 %
Embecta Corp	10.25 %
Cryoport inc	10.07 %
Universal Health Services Inc	10.06 %
Solventum Corporation	9.97 %
Kiniksa Pharmaceuticals International Plc	9.86 %
Mimedx Group Inc	9.73 %
Penumbra Inc	9.58 %
Pacific Health Care Organization Inc	9.57 %
Insulet Corporation	9.55 %
Progyny Inc	9.03 %
Siga Technologies Inc	8.94 %
Tenet Healthcare Corp	8.91 %

Date modified: 2026-09-26T06:58:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.